These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37036202)

  • 1. High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers.
    Monteiro da Rocha A; Allan A; Block T; Creech J; Herron TJ
    J Vis Exp; 2023 Mar; (193):. PubMed ID: 37036202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human perinatal stem cell derived extracellular matrix enables rapid maturation of hiPSC-CM structural and functional phenotypes.
    Block T; Creech J; da Rocha AM; Marinkovic M; Ponce-Balbuena D; Jiménez-Vázquez EN; Griffey S; Herron TJ
    Sci Rep; 2020 Nov; 10(1):19071. PubMed ID: 33149250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput longitudinal electrophysiology screening of mature chamber-specific hiPSC-CMs using optical mapping.
    Allan A; Creech J; Hausner C; Krajcarski P; Gunawan B; Poulin N; Kozlowski P; Clark CW; Dow R; Saraithong P; Mair DB; Block T; Monteiro da Rocha A; Kim DH; Herron TJ
    iScience; 2023 Jul; 26(7):107142. PubMed ID: 37416454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells.
    Takeda M; Miyagawa S; Fukushima S; Saito A; Ito E; Harada A; Matsuura R; Iseoka H; Sougawa N; Mochizuki-Oda N; Matsusaki M; Akashi M; Sawa Y
    Tissue Eng Part C Methods; 2018 Jan; 24(1):56-67. PubMed ID: 28967302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.
    Yang X; Papoian T
    J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hiPSC-CM Monolayer Maturation State Determines Drug Responsiveness in High Throughput Pro-Arrhythmia Screen.
    da Rocha AM; Campbell K; Mironov S; Jiang J; Mundada L; Guerrero-Serna G; Jalife J; Herron TJ
    Sci Rep; 2017 Oct; 7(1):13834. PubMed ID: 29061979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological mechanisms of vandetanib-induced cardiotoxicity: Comparison of action potentials in rabbit Purkinje fibers and pluripotent stem cell-derived cardiomyocytes.
    Lee HA; Hyun SA; Byun B; Chae JH; Kim KS
    PLoS One; 2018; 13(4):e0195577. PubMed ID: 29630634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Enhanced Structural Maturity of hiPSC-Cardiomyocytes Better for the Detection of Drug-Induced Cardiotoxicity?
    Van de Sande D; Ghasemi M; Watters T; Burton F; Pham L; Altrocchi C; Gallacher DJ; Lu H; Smith G
    Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
    Liang P; Lan F; Lee AS; Gong T; Sanchez-Freire V; Wang Y; Diecke S; Sallam K; Knowles JW; Wang PJ; Nguyen PK; Bers DM; Robbins RC; Wu JC
    Circulation; 2013 Apr; 127(16):1677-91. PubMed ID: 23519760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes.
    Lee S; Lee HA; Choi SW; Kim SJ; Kim KS
    Toxicol Appl Pharmacol; 2016 Apr; 296():42-53. PubMed ID: 26821276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of in vitro models of stem cell-derived cardiomyocytes to screen for potential cardiotoxicity of chemicals.
    Shi M; Tien NT; de Haan L; Louisse J; Rietjens IMCM; Bouwmeester H
    Toxicol In Vitro; 2020 Sep; 67():104891. PubMed ID: 32446838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells.
    Sharma A; Burridge PW; McKeithan WL; Serrano R; Shukla P; Sayed N; Churko JM; Kitani T; Wu H; Holmström A; Matsa E; Zhang Y; Kumar A; Fan AC; Del Álamo JC; Wu SM; Moslehi JJ; Mercola M; Wu JC
    Sci Transl Med; 2017 Feb; 9(377):. PubMed ID: 28202772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Drug-Induced Torsades de Pointes Arrhythmia Mechanisms Using hiPSC-CM Syncytial Monolayers in a High-Throughput Screening Voltage Sensitive Dye Assay.
    da Rocha AM; Creech J; Thonn E; Mironov S; Herron TJ
    Toxicol Sci; 2020 Feb; 173(2):402-415. PubMed ID: 31764978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of Ratiometric Fluorescence Measurements of the Voltage Sensitive Dye Di-4-ANEPPS to Examine Action Potential Characteristics and Drug Effects on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Hortigon-Vinagre MP; Zamora V; Burton FL; Green J; Gintant GA; Smith GL
    Toxicol Sci; 2016 Dec; 154(2):320-331. PubMed ID: 27621282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Electrical Stimulation on hiPSC-CM Responses to Classic Ion Channel Blockers.
    Wei F; Pourrier M; Strauss DG; Stockbridge N; Pang L
    Toxicol Sci; 2020 Apr; 174(2):254-265. PubMed ID: 32040191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Induced Pluripotent Stem Cell-Derived Non-Cardiomyocytes Modulate Cardiac Electrophysiological Maturation Through Connexin 43-Mediated Cell-Cell Interactions.
    Biendarra-Tiegs SM; Clemens DJ; Secreto FJ; Nelson TJ
    Stem Cells Dev; 2020 Jan; 29(2):75-89. PubMed ID: 31744402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53 Activation Promotes Maturational Characteristics of Pluripotent Stem Cell-Derived Cardiomyocytes in 3-Dimensional Suspension Culture Via FOXO-FOXM1 Regulation.
    Velayutham N; Garbern JC; Elwell HLT; Zhuo Z; Rüland L; Elcure Alvarez F; Frontini S; Rodriguez Carreras Y; Eichholtz M; Ricci-Blair E; Shaw JY; Bouffard AH; Sokol M; Mancheño Juncosa E; Rhoades S; van den Berg D; Kreymerman A; Aoyama J; Höfflin J; Ryan H; Ho Sui S; Lee RT
    J Am Heart Assoc; 2024 Jul; 13(13):e033155. PubMed ID: 38934864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological and calcium-handling development during long-term culture of human-induced pluripotent stem cell-derived cardiomyocytes.
    Seibertz F; Sutanto H; Dülk R; Pronto JRD; Springer R; Rapedius M; Liutkute A; Ritter M; Jung P; Stelzer L; Hüsgen LM; Klopp M; Rubio T; Fakuade FE; Mason FE; Hartmann N; Pabel S; Streckfuss-Bömeke K; Cyganek L; Sossalla S; Heijman J; Voigt N
    Basic Res Cardiol; 2023 Apr; 118(1):14. PubMed ID: 37020075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes.
    Feaster TK; Casciola M; Narkar A; Blinova K
    J Vis Exp; 2022 Dec; (190):. PubMed ID: 36591970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.